Smart delivery for superior treatment.

For patients, worldwide.

As a bio-pharmaceutical company, AMW provides patients with biodegradable drug delivery systems for value-added and cost-effective therapies. With state-of-the-art production facilities in Germany, the entire pharmaceutical value chain is covered. Our employees, with their individual ideas and skills, are crucial to our success.

Our focus

Research & Development

Cutting-edge technology and know-how in extrusion: AMW’s technology platform as the basis for our growing development pipeline of drug delivery systems

Products

Our implants goserelin and leuprorelin for the treatment of hormone-sensitive tumors

Services

We support our pharma and biotech partners locally and globally – from technology collaboration to contract development

We cover the entire value chain for drug delivery systems – from (co-)development and manufacturing to commercialization or out-licensing.

Careers at AMW

Latest News

AMW Again Reports Record Financial Results 2023, CEO Philipp Karbach Becomes Shareholder, Investment Program For Employees Launched

Warngau, June 3, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today reported financial results for the year ended December 31, 2023. AMW posted a 2023 consolidated record revenue of EUR 29.4 million and achieved operating profitability for the second consecutive year. In addition, the Company reported a partial […]

read more

AMW Receives Notified Body Opinion by TÜV SÜD for its Leuprorelin Implant in Pre-Filled Syringe

Warngau, Germany, May 15, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced that it has received the final report of the Notified Body Opinion (NBO) for its leuprorelin implant in pre-filled syringes. The NBO completes a diligent conformity review procedure by a notified body, in this case […]

read more

AMW welcomes Ilse Aigner, President of the Bavarian State Parliament, at the Warngau site to share a success story

Warngau, Germany, April 11, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, was delighted to welcome today the President of the Bavarian State Parliament, Ilse Aigner, to its headquarters in Warngau near Munich, Germany. In her speech to AMW employees, Ms. Aigner acknowledged the Company’s innovative strength and emphasized […]

read more